Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Tris Pharma’s opioid alternative has scored a third win in a trio of clinical trials, providing the biotech with the data ...

Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

A new review reaffirms that spinal steroid injections only reduce neck and back pain for a few months, but they don't improve function or reduce the need for surgery.

People who take over-the-counter pain relievers after a concussion may recover faster than those who do not take pain relievers, according to a preliminary study.

Do you experience chest pain when anxiety strikes? Relax; it's more common than you think, and there are ways to address it.

Researchers at WashU Medicine and Stanford University developed a compound that relieves pain in mice but doesn't affect the ...

Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...

TAMPA, Fla. — Yankees designated hitter Giancarlo Stanton is still going with a conservative treatment on his tennis elbow in both arms.

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...

Discover the distinctive symptoms of liver pain, common underlying conditions, and effective treatment options to protect ...